Table 4.
HSCT outcome | HR | 95% CI | P |
---|---|---|---|
Overall mortality | |||
Low* | 1 | ||
Intermediate-1 | 1.97 | 0.66-5.85 | .22 |
Intermediate-2 | 3.15 | 1.08-9.22 | .04 |
High | 4.11 | 1.44-11.78 | .01 |
Global P = .01 | |||
Relapse or death | |||
Low* | 1 | ||
Intermediate-1 | 2.40 | 0.81-7.06 | .11 |
Intermediate-2 | 3.68 | 1.27-10.69 | .02 |
High | 4.39 | 1.53-12.61 | .01 |
Global P = .01 | |||
Relapse | |||
Low | 0 | 0 | .05† |
Intermediate-1 | 0.95 | 0.34-2.62 | .92 |
Intermediate-2 | 0.54 | 0.16-1.86 | .33 |
High* | 1 | ||
Global P = .19 | |||
NRM | |||
Low* | 1 | ||
Intermediate-1 | 1.41 | 0.45-4.44 | .56 |
Intermediate-2 | 3.19 | 1.07-9.50 | .04 |
High | 3.41 | 1.15-10.09 | .03 |
Global P = .004 |
There were no relapses in the low risk group.
Referent category.
The P value was estimated from log-rank test (direct comparison between low-risk and high-risk groups).